Corridor Pharmaceuticals, Inc. is a biotechnology company based out of 1122 Kenilworth Dr, Towson, Maryland, United States.
View Top Employees from Corridor Pharmaceuticals IncWebsite | http://www.corridorpharma.com |
Revenue | $5.4 million |
Funding | $16.6 million |
Employees | View employees |
Founded | 2007 |
Address | 1122 Kenilworth Dr. Ste. 401, Towson, Maryland 21204, US |
Phone | (410) 616-0804 |
Technologies |
JavaScript,
HTML,
Google Analytics
+8 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Health Care, Therapeutics |
Competitors | Pearl Therapeutics, Pulmatrix Inc., SPYRYX Biosciences, Savara Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Corridor Pharmaceuticals Inc employee's phone or email?
The Corridor Pharmaceuticals Inc annual revenue was $5.4 million in 2023.
Corridor Pharmaceuticals Inc is based in Towson, Maryland.
The NAICS codes for Corridor Pharmaceuticals Inc are [3254, 325, 32].
The SIC codes for Corridor Pharmaceuticals Inc are [283, 28].